SeedInvest’s Weekly Highlights: Cytonics is Granted Another Patent & More

Click to rate this post!
[Total: 0 Your Rating: 0]

Cytonics, a biotech company developing diagnostics and therapeutics for osteoarthritis, was recently issued an Australian patent for its lead drug candidate, CYT-108.

Perfitly, an AI-Powered AR/VR interactive online fitting room, is hosting a virtual product demo and investor Q&A next Thursday, February 18th at 4pm ET.

Swiftmile, a solar-powered electric bike sharing platform and SeedInvest portfolio company, recently partnered with Stantec GenerationAVโ„ข to bring the company’s electric micromobility hubs to cities, municipalities, and campuses.

HelloMD, a digital health platform for non-traditional care through medical cannabis therapies and SeedInvest portfolio deal, has formed a strategic partnership with ZYUS Life Sciences to increase national access to patient care.


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.